Johnson & Johnson has announced a new initiative in the United Arab Emirates aimed at supporting access to liquid biopsy testing for patients diagnosed with metastatic non-small cell lung cancer (NSCLC). Through the program, the company will cover the cost of liquid biopsy testing for eligible patients where diagnostic testing may not be covered by […] The post Johnson & Johnson Launches Initiative to Support Access to Liquid Biopsy Testing for Non-Small Cell Lung Cancer in the UAE appeared first on Web-Release.
Breaking News:
- DANIEL’S ROOM BRINGS COLLECTIBLE ART TO THE CAFÉ EXPERIENCE AT DUBAI MALL
- Sanofi Announces Expanded Proactive Care for a Disease Modifying Therapy in Type 1 Diabetes
- Aldar partners with PureHealth to launch wellness and health longevity-driven living environments in Abu Dhabi
- Introducing the All-New Nissan Tekton: A Bold New SUV Driving Nissan’s Growth in India and Beyond
- Hisense Makes Home the Best Seat for the FIFA World Cup 2026TM
- IBM and Red Hat Expand Lightwell with New Offerings to Build the Trust Infrastructure for AI-Era Open Source
- EHRDC celebrates graduation of first cohort of Chief Financial Officer Program to prepare future Emirati financial leaders
- ECI Supports USD 50 Million Trade Finance Facility for Gerald Group with ADCB to Accelerate UAE Non-Oil Exports
Tuesday, July 14